Literature DB >> 22246478

Increasing fear of adverse effects drops intention to vaccinate after the introduction of prophylactic HPV vaccine.

Alexandros Sotiriadis1, Themistoklis Dagklis, Vaia Siamanta, Konstantinos Chatzigeorgiou, Theodoros Agorastos.   

Abstract

PURPOSE: The purpose of this study was (1) to explore for socio-demographic factors that could potentially affect the intention of women to vaccinate themselves, their 13-year-old daughter and their 13-year-old son against HPV, and (2) to investigate the main reasons for declining vaccination.
METHODS: A structured questionnaire was used in participants of the project (N = 5,249). Logistic regression analysis was applied in order to examine the correlation between vaccine acceptability and a list of potential predictors. In women declining vaccination, the reported reasons for decline were analyzed.
RESULTS: Residence in rural areas and low to medium tiers of family income were the most constant factors in favor of intention to vaccinate. Receiving information from a healthcare professional was found to positively affect vaccine acceptability for the woman herself, but it did not affect her intention to vaccinate her daughter or her son. The acceptance rates decreased significantly after the vaccine became available, both for the women themselves and for their daughters or sons. During the same year, a shift was noted in the reason for declining vaccination; the self-perception of insufficient knowledge significantly decreased and the fear of adverse effects significantly increased in all three cases.
CONCLUSION: Apart from demographic factors which may favor or disfavor vaccine acceptability, the intention to vaccinate decreased significantly and the proportion of women rejecting vaccination for safety concerns increased significantly after the introduction of the vaccine, coinciding with isolated cases of negative publicity and highlighting the potential of misinformation by the media.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22246478     DOI: 10.1007/s00404-011-2208-z

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  17 in total

1.  HPV vaccine acceptability in high-risk Greek men.

Authors:  Lea Hoefer; Savas Tsikis; George Bethimoutis; Electra Nicolaidou; Vassilios Paparizos; Christina Antoniou; Antonios Kanelleas; Leonidas Chardalias; Georgios-Emmanouil Stavropoulos; John Schneider; Angella Charnot-Katsikas
Journal:  Hum Vaccin Immunother       Date:  2017-10-24       Impact factor: 3.452

2.  Effect on HPV vaccination in Japan resulting from news report of adverse events and suspension of governmental recommendation for HPV vaccination.

Authors:  Akiko Morimoto; Yutaka Ueda; Tomomi Egawa-Takata; Asami Yagi; Yoshito Terai; Masahide Ohmichi; Tomoyuki Ichimura; Toshiyuki Sumi; Hiromi Murata; Hideharu Kanzaki; Hidekatsu Nakai; Masaki Mandai; Kiyoshi Yoshino; Masami Fujita; Tadashi Kimura; Junko Saito; Tomotaka Sobue; Nobumichi Nishikawa; Masayuki Sekine; Takayuki Enomoto; Yorihiko Horikoshi; Tetsu Takagi
Journal:  Int J Clin Oncol       Date:  2014-07-09       Impact factor: 3.402

3.  Fear, knowledge, and vaccination behaviors among women in Northern Nigeria.

Authors:  Ryoko Sato; Benjamin Fintan
Journal:  Hum Vaccin Immunother       Date:  2020-02-21       Impact factor: 3.452

4.  Associations Between Exposure to and Expression of Negative Opinions About Human Papillomavirus Vaccines on Social Media: An Observational Study.

Authors:  Adam G Dunn; Julie Leask; Xujuan Zhou; Kenneth D Mandl; Enrico Coiera
Journal:  J Med Internet Res       Date:  2015-06-10       Impact factor: 5.428

Review 5.  Safety of human papillomavirus vaccines: a review.

Authors:  Michela Stillo; Paloma Carrillo Santisteve; Pier Luigi Lopalco
Journal:  Expert Opin Drug Saf       Date:  2015-02-18       Impact factor: 4.250

6.  Quadrivalent HPV vaccine safety review and safety monitoring plans for nine-valent HPV vaccine in the United States.

Authors:  Julianne Gee; Cindy Weinbaum; Lakshmi Sukumaran; Lauri E Markowitz
Journal:  Hum Vaccin Immunother       Date:  2016-03-30       Impact factor: 3.452

7.  Reasons for receiving or not receiving HPV vaccination in primary schoolgirls in Tanzania: a case control study.

Authors:  Deborah Watson-Jones; Keith Tomlin; Pieter Remes; Kathy Baisley; Riziki Ponsiano; Selephina Soteli; Silvia de Sanjosé; John Changalucha; Saidi Kapiga; Richard J Hayes
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

8.  Vaccination against human papillomavirus among 865 female students from the health professions in central Greece: a questionnaire-based cross-sectional study.

Authors:  Dimitrios Papagiannis; George Rachiotis; Emmanouil K Symvoulakis; Alexandros Daponte; Ioanna N Grivea; George A Syrogiannopoulos; Christos Hadjichristodoulou
Journal:  J Multidiscip Healthc       Date:  2013-11-28

9.  Greek health professionals' perceptions of the HPV vaccine, state policy recommendations and their own role with regards to communication of relevant health information.

Authors:  Christina Karamanidou; Kostas Dimopoulos
Journal:  BMC Public Health       Date:  2016-06-03       Impact factor: 3.295

10.  Development of an efficient strategy to improve HPV immunization coverage in Japan.

Authors:  Asami Yagi; Yutaka Ueda; Tomomi Egawa-Takata; Yusuke Tanaka; Akiko Morimoto; Yoshito Terai; Masahide Ohmichi; Tomoyuki Ichimura; Toshiyuki Sumi; Hiromi Murata; Hidetaka Okada; Hidekatsu Nakai; Masaki Mandai; Kiyoshi Yoshino; Tadashi Kimura; Junko Saito; Risa Kudoh; Masayuki Sekine; Takayuki Enomoto; Kei Hirai; Yorihiko Horikoshi; Tetsu Takagi; Kentaro Shimura
Journal:  BMC Public Health       Date:  2016-09-23       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.